User perspective of an intelligent Clinical Decision Support software (LungHealth) as part of the MISSION project in Greater Manchester (ID 625)
Chiesi Ltd
Abstract
Background to Project
Asthma and COPD are common respiratory conditions in the UK and are associated with significant morbidity and mortality. Guidelines recommend respiratory patients should receive reviews annually, however it is estimated that only 30% of people living with asthma and <20% people living with COPD, in the UK receive even basic levels of care.
Greater Manchester (GM) is ranked 6 out of 326 in the index of multiple deprivation (1 being the most deprived) and has a greater prevalence and worse asthma outcomes than the national average. It has been reported that those living in the most deprived areas of England face the worst healthcare inequalities.
This project aimed to evaluate a digital approach to respiratory reviews and the impact of implementing an intelligent Clinical Decision Support System software (LungHealth) in the form of a computer-guided consultation (CGC).
The MISSION project is a collaborative working project between Chiesi Ltd and Health Innovation Manchester (with NSHI providing clinical services). GP Practices in GM were invited to participate and recruitment took place from September 2024 to June 2025.
Measurement of Improvement
The LungHealth software received an overall average score of 4.9 (out of 6).
• 79 % (23/29) respondents hadn’t received formal respiratory training.
• 59% (17/29) agreed the LungHealth software allowed then to provide improved respiratory reviews.
• 66% (19/29) agreed with regular use it would improve knowledge and practice in managing patients with respiratory conditions.
• 90% (26/29) agreed they were more confident with recognising exacerbations and acute presentations.
• 76% (22/29) felt more confident about decision making around non-pharmacological interventions.
Lessons learned
Users felt that the LungHealth software increased their confidence in many areas of the respiratory consultation, e.g. when to refer to secondary care, on decision-making with regards to escalating and de-escalating treatment. Many (66%) felt with regular use it would improve their practice and knowledge, and majority (90%) were more confident with regards to recognising symptoms and acute presentations.
Funding: MISSION is a collaborative working project between Health Innovation Manchester and Chiesi Ltd with services provided by National Services for Health Improvement.
Conflicts of interest: Saarah Niazi-Ali is an employee of Chiesi.
The conference has been instigated and organised by PCRS. We are grateful to sponsors and exhibitors who have contributed funding towards this event in return for exhibition space. Neither sponsors or exhibitors have had any input into the agenda or the selection of speakers with the exception of any sponsored satellite symposia which are clearly indicated. View the full list of sponsors.
The conference social programme - dinner, drinks and disco - is not covered by sponsorship or exhibition fees.